Physician Education: Bridging Clinical Research and Patient Care

Faculty Profile

Associate Professor of Medicine and Epidemiology
Johns Hopkins University School of Medicine
Baltimore, MD

Topics of Professional Interest:
  • HIV and alcohol/substance misuse
  • Interventions for alcohol use among persons with HIV
  • HIV and mental health
  • Alcohol and HIV
  • Alcohol use disorders and treatment of alcohol use in HIV
  • Screening, brief intervention, and referral to treatment (SBIRT)
  • Substance misuse and HIV
Current Professional Summary:

Dr Chander is an Associate Professor at Johns Hopkins University School of Medicine and a member of the Division of General Internal Medicine. She is a provider in the Johns Hopkins HIV Clinic and performs NIH-funded research related to alcohol and drug use among persons with HIV infection. She is specifically interested in interventions for substance abuse in HIV clinical settings.

Committees and Organizations:
  • Society of General Internal Medicine
  • American College of Physicians
  • Research Society on Alcoholism
Honors and Awards:
  • Alpha Omega Alpha Medical Honor Society (1997)
Education:
  • Wesleyan University, BA in History with High Honors (1993)
  • Jefferson Medical College, MD, Medicine (1997)
  • Rhode Island Hospital, Brown University School of Medicine, Residency in Internal Medicine (1997-2000)
  • Johns Hopkins University, General Internal Medicine Fellowship (2001-2004)
  • Johns Hopkins University Bloomberg School of Public Health, Master of Public Health (2002)
Selected Publications:
  1. Chander G, Stanton C, Hutton HE, et al. Are smokers with HIV using information and communication technology? Implications for behavioral interventions. AIDS Behav. 2011. [Epub ahead of print]
  2. Neblett RC, Hutton HE, Lau B, McCaul ME, Moore RD, Chander G. Alcohol consumption among HIV-infected women: impact on time to antiretroviral therapy and survival. J Womens Health (Larchmt). 2011;20:279-286.
  3. Chander G, Himelhoch S, Fleishman JA, et al. HAART receipt and viral suppression among HIV-infected patients with co-occurring mental illness and illicit drug use. AIDS Care. 2009;21:655-663.
  4. Himelhoch S, Josephs JS, Chander G, Korthuis PT, Gebo KA. Use of outpatient mental health services and psychotropic medications among HIV-infected patients in a multisite, multistate study. Gen Hosp Psychiatry. 2009;31:538-545.
  5. Himelhoch S, Brown CH, Walkup J, Chander G, et al. HIV patients with psychiatric disorders are less likely to discontinue HAART. AIDS. 2009;23:1735-1742.
  6. Chander G, Josephs J, Fleishman JA, et al. Alcohol use among HIV-infected persons in care: results of a multi-site survey. HIV Med. 2008;9:196-202.
  7. Hicks PL, Mulvey KP, Chander G, et al. The impact of illicit drug use and substance abuse treatment on adherence to HAART. AIDS Care. 2007;19:1134-1140.
  8. Chander G, Himelhoch S, Moore RD. Substance abuse and psychiatric disorders in HIV-positive patients: epidemiology and impact on antiretroviral therapy. Drugs. 2006;66:769-789.
  9. Chander G, Lau B, Moore RD. Hazardous alcohol use: a risk factor for non-adherence and lack of suppression in HIV infection. JAIDS. 2006;43:411-417.
  10. Chander G, Sulkowski MS, Jenckes MW, et al. Treatment of chronic hepatitis C: a systematic review. Hepatology. 2002;36:S135-S144.

Presentations

14th Annual Clinical Conference for the Ryan White HIV/AIDS Program